comparemela.com

Latest Breaking News On - International medical approval - Page 10 : comparemela.com

Antengene Announces NDA Approval by NMPA for XPOVIO®, China s First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma

/PRNewswire/ Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce that ATG-010 (selinexor, brand name: XPOVIO®), a.

United statesHong kongUnited kingdomSouth koreaKevin lynchJay meiAsia pacificPeter qianSelective inhibitor of nuclear exportKaryopharm therapeutics incAntengene corporationInternational myeloma working groupDrug administrationSelective inhibitor of nuclearAntengene corporation limitedNational medical products administration

Antengene Announces NDA Approval by NMPA for XPOVIO®, China s First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma

/PRNewswire/ Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce that ATG-010 (selinexor, brand name: XPOVIO®), a.

United statesHong kongUnited kingdomSouth koreaKevin lynchJay meiAsia pacificPeter qianSelective inhibitor of nuclear exportKaryopharm therapeutics incAntengene corporationInternational myeloma working groupDrug administrationSelective inhibitor of nuclearAntengene corporation limitedNational medical products administration

Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve

/PRNewswire/ Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin).

United statesKasugai cyberknifeBeth kaplanChristy maginnHiroshi takahashiExchange commissionJapanese ministry of healthAccuray incorporatedPrnewswire accuray incorporatedJapanese ministryRobotic radiosurgery systemCyberknife systemSuzanne winterGeneral directorImportant safety informationPrivate securities litigation reform act

Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve

/PRNewswire/ Accuray Incorporated (NASDAQ: ARAY) announced today it has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin).

United statesKasugai cyberknifeBeth kaplanChristy maginnHiroshi takahashiExchange commissionJapanese ministry of healthAccuray incorporatedPrnewswire accuray incorporatedJapanese ministryRobotic radiosurgery systemCyberknife systemSuzanne winterGeneral directorImportant safety informationPrivate securities litigation reform act

Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China

/PRNewswire/ Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for.

Inner mongoliaNei mongolSouth africaLinqi zhangBrii bioRogers luoUs national institute of healthClinical trial groupDrug administrationNational clinical research centerGlobal healthBrii biosciencesNational medical products administrationInfectious diseases research centerTsinghua universityUse authorization

vimarsana © 2020. All Rights Reserved.